Table 1.
Prevalence, relative risk (RR) and population attributable fractions (PAF) of overweight-related diseases
| Comorbidity | Prevalence (%) | RR (95 % CI) | PAF (%) | |||||
|---|---|---|---|---|---|---|---|---|
| Male | Female | Male | 95 % CI | Female | 95 % CI | Male | Female | |
| CHD | 10·1 | 15·0 | 1·29 | 1·18, 1·41 | 1·80 | 1·64, 1·98 | 2·8 | 10·7 |
| HPT | 19·4 | 31·9 | 1·28 | 1·10, 1·50 | 1·65 | 1·24, 2·19 | 5·2 | 17·2 |
| Asthma | 4·0 | 3·9 | 1·35 | 1·15–1·58 | 1·35 | 1·15–1·58 | 1·4 | 1·3 |
| NIDDM | 10·7 | 11·2 | 1·46 | 1·21–5·23 | 3·35 | 1·21–5·23 | 4·7 | 20·8 |
| Gallstones | 3·3 | 7·7 | 1·08 | 1·07–1·10 | 1·04 | 1·02–1·07 | 0·3 | 0·3 |
| Kidney disease | 15·0 | 17·0 | 1·43 | 1·31–2·79 | 1·74 | 1·31–2·79 | 6·1 | 11·2 |
HPT, hypertension; NIDDM, non-insulin-dependent diabetes mellitus.